SCHEDULE: North Peak Capital Files Schedule 13G Amendment

North Peak Capital Management and affiliated entities have filed an amendment to their Schedule 13G, reporting 0% beneficial ownership of Haemonetics Corp. common stock as of March 31, 2026.

Summary

• This filing is an amendment to a Schedule 13G, which is used by investors who beneficially own more than 5% of a company's stock but do not intend to influence or change control of the company.
• The reporting persons include North Peak Capital Management, LLC, North Peak Capital GP, LLC, and several limited partnerships (Fund I, Fund II, Alpha Fund, Ultra Fund), as well as individuals Michael Kevin Kahan and Jeremy Steven Kahan.
• As of the event date, March 31, 2026, all reporting persons collectively hold 0.00 shares of Haemonetics Corp. common stock.
• Consequently, the aggregate amount beneficially owned by each reporting person is 0.00, representing 0% of the class of securities.
• The filing explicitly states that each reporting person disclaims beneficial ownership of shares held by other reporting persons and that the filing should not be construed as an admission of beneficial ownership or group membership for the purpose of Section 13(d) or 13(g) of the Act.
• The filing is made pursuant to Rule 13d-1(b) and the reporting persons are classified as investment advisers (IA) and other (OO, PN, HC, IN).

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, as it indicates a complete exit or reduction to zero beneficial ownership by a previously reporting entity, which could signal a lack of confidence or a strategic shift away from the company.

Negatives

• Reporting persons collectively hold 0% of Haemonetics Corp. common stock, indicating no significant investment or control interest.
• The filing is an amendment, suggesting a change in reporting status or holdings, which in this case is a reduction to zero ownership.

Risks

• The filing does not contain any specific risks related to Haemonetics Corp. or the reporting persons' investment strategy.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding future holdings or intentions.

Management Comments

• Each Reporting Person disclaims beneficial ownership of the shares of Common Stock held directly by the other Reporting Persons.
• Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.
• Each Reporting Person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act.
• Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors and investment managers. A filing showing 0% ownership after a previous filing indicates a complete divestment or a change in reporting thresholds, which is a significant shift in the investor's relationship with the company.

Stakeholder Impact

• Shareholders may note the absence of North Peak Capital as a significant beneficial owner, which could influence market perception depending on their previous stake and investment strategy.
• The company's management may observe the change in its investor base, though the impact is minimal given the 0% ownership.

Next Steps

• Monitor future filings by North Peak Capital Management and its affiliates for any re-initiation of a position in Haemonetics Corp.

Key Dates

Keywords

Schedule 13G, SEC Filing, Haemonetics Corp, North Peak Capital Management, Beneficial Ownership, Securities Exchange Act, Investment Adviser, Amendment